Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.reuma.2014.08.002 | DOI Listing |
J Assoc Physicians India
April 2024
Department of Medicine, All India Institute of Medical Sciences (AIIMS), Delhi, India.
Rheumatology (Oxford)
February 2024
Rheumatology Department, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain.
Objective: Joint involvement in SLE is the most frequent manifestation and shows a wide heterogeneity. It has not a valid classification and it is often underestimated. Subclinical inflammatory musculoskeletal involvement is not well known.
View Article and Find Full Text PDFClin Rheumatol
November 2023
Rheumatology Section, Department of Medicine, University of Verona, P. le L.A. Scuro 10, 37134, Verona, Italy.
The aim of this study is to characterise lupus-related arthritis and assess if the presence of ultrasound-detected erosions could be associated with belimumab in the treatment of systemic lupus erythematosus (SLE) articular manifestations. We performed a spontaneous, monocentric, retrospective, and observational study. We enrolled patients affected by SLE with articular involvement treated with belimumab.
View Article and Find Full Text PDFImmun Inflamm Dis
October 2022
Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Objective: Typically, Jaccoud arthropathy (JA) is characterized by joint deformation without bone erosion. However, some recent studies have shown that bone erosion also occurs in JA; however, this remains controversial. To date, there have been no unified diagnostic standards for JA.
View Article and Find Full Text PDFRheumatol Ther
June 2022
Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Although the clinical approach to the management of musculoskeletal manifestations in systemic lupus erythematosus (SLE) is often similar to that of rheumatoid arthritis (RA), there are distinct differences in immunopathogenesis, structural and imaging phenotypes and therapeutic evidence. Additionally, there are few published comparisons of these diseases. The objective of this narrative literature review is to compare the immunopathogenesis, structural features, magnetic resonance imaging (MRI) and musculoskeletal ultrasound (MSUS) studies and management of joint manifestations in RA and SLE.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!